Correlation Between Cingulate Warrants and OncoCyte Corp

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and OncoCyte Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and OncoCyte Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and OncoCyte Corp, you can compare the effects of market volatilities on Cingulate Warrants and OncoCyte Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of OncoCyte Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and OncoCyte Corp.

Diversification Opportunities for Cingulate Warrants and OncoCyte Corp

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between Cingulate and OncoCyte is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and OncoCyte Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on OncoCyte Corp and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with OncoCyte Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of OncoCyte Corp has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and OncoCyte Corp go up and down completely randomly.

Pair Corralation between Cingulate Warrants and OncoCyte Corp

Assuming the 90 days horizon Cingulate Warrants is expected to generate 5.4 times more return on investment than OncoCyte Corp. However, Cingulate Warrants is 5.4 times more volatile than OncoCyte Corp. It trades about 0.03 of its potential returns per unit of risk. OncoCyte Corp is currently generating about -0.17 per unit of risk. If you would invest  4.49  in Cingulate Warrants on September 12, 2024 and sell it today you would lose (0.86) from holding Cingulate Warrants or give up 19.15% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy90.91%
ValuesDaily Returns

Cingulate Warrants  vs.  OncoCyte Corp

 Performance 
       Timeline  
Cingulate Warrants 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Cingulate Warrants has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly weak technical and fundamental indicators, Cingulate Warrants may actually be approaching a critical reversion point that can send shares even higher in January 2025.
OncoCyte Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days OncoCyte Corp has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's fundamental indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Cingulate Warrants and OncoCyte Corp Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Cingulate Warrants and OncoCyte Corp

The main advantage of trading using opposite Cingulate Warrants and OncoCyte Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, OncoCyte Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in OncoCyte Corp will offset losses from the drop in OncoCyte Corp's long position.
The idea behind Cingulate Warrants and OncoCyte Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.

Other Complementary Tools

My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Stocks Directory
Find actively traded stocks across global markets
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Positions Ratings
Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance